Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat-Dx Rise – a high-capacity version of the QIAstat-Dx ...
The clinical laboratory occupies a central role in modern healthcare by providing essential data that guide patient management and treatment decisions. At the heart of this process lies the total ...
Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results